Trial site
Pioneer Research Solutions, Inc.
- 8running trials
- 11closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)5 trials
- Gout4 trials
- Chronic kidney disease2 trials
- Gastroparesis2 trials
- Liver cirrhosis2 trials
- COPD1 trial
- Graves' disease1 trial
- High blood pressure1 trial
- Lupus (SLE)1 trial
- Rheumatoid arthritis1 trial
- Schizophrenia1 trial
- Phase
- Phase 210 trials
- Phase 37 trials
- Phase 41 trial
- Status
- Completed10 trials
- Active, not recruiting4 trials
- Recruiting4 trials
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- Boehringer Ingelheim2 trials
- CinDome Pharma, Inc.2 trials
- LG Chem2 trials
- Regeneron Pharmaceuticals2 trials
- Amgen1 trial
- and 11 more
Running trials
Recruiting
Recruiting
Recruiting
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Recruiting
Active, not recruiting
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
Active, not recruiting
A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)2 recruiting
- Liver cirrhosis2 recruiting
- Gout1 recruiting
- Schizophrenia1 recruiting
Closed trials
Completed
Completed
Completed
Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH
Completed
Natrunix or Placebo in Combination With Methotrexate in Rheumatoid Arthritis
Completed
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Completed
Completed
Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients
Completed
A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia
Terminated
Completed
Efocipegtrutide (HM15211) in Adults With Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH)
Completed
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
Site data: ClinicalTrials.govUpdated 17 Nov 2026